Evidence map›Paper›PMID 33300241›Full record

SynthesisAmerican journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons2021

Meta-analysis and meta-regression of outcomes for adult living donor liver transplantation versus deceased donor liver transplantation.

Arianna Barbetta, Mayada Aljehani, Michelle Kim, Christine Tien, Aaron Ahearn, Hannah Schilperoort, Linda Sher, Juliet Emamaullee

Open access · bronzeAbstract readMeta-Analysis
In one paragraph

Synthesis in American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed, 1 pooled it
7.8field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

32 citing papers in PubMed, 1 synthesis or guideline pooled it, 80 citations in OpenAlex.

  1. Guideline
  2. Article
  3. The Role of Gut Microbiota in Liver Regeneration After Partial Hepatectomy: New Evidence From Animal and Human Studies.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2026
    Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. American perspectives for LDLT in 2024.Updates in surgery · 2025
    Review
  11. Review
  12. Review
  13. Review
  14. Article
  15. Article
  16. Liver Transplantation for Autoimmune Hepatitis: 20 Years of Tertiary Centre Experience.The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology · 2024
    Article
  17. Financial toxicity in living donor liver transplantation: A call to action for financial neutrality.American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons · 2024
    Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Arianna BarbettaDepartment of Surgery, University of Southern California, Los Angeles, California, USA.
Mayada AljehaniLawrence J Ellison Institute for Transformative Medicine, University of Southern California, Los Angeles, California, USA.
Michelle KimDepartment of Surgery, University of Southern California, Los Angeles, California, USA.
Christine TienKeck School of Medicine, University of Southern California, Los Angeles, California, USA.
Aaron AhearnDepartment of Surgery, University of Southern California, Los Angeles, California, USA.
Hannah SchilperoortNorris Medical Library, University of Southern California, Los Angeles, California, USA.
Linda SherDepartment of Surgery, University of Southern California, Los Angeles, California, USA.
Juliet EmamaulleeDepartment of Surgery, University of Southern California, Los Angeles, California, USA.ORCID 0000-0003-4238-3057
University of Southern California · US

Funding

Immunologic Biomarkers of Rejection in Clinical Liver TransplantationK08CA245220 · NCI · UNIVERSITY OF SOUTHERN CALIFORNIA · PI EMAMAULLEE, JULIET · 2020 to 2024
$1.3M
NCI NIH HHS K08 CA245220
6 · The paper itself

Abstract

Prior single center or registry studies have shown that living donor liver transplantation (LDLT) decreases waitlist mortality and offers superior patient survival over deceased donor liver transplantation (DDLT). The aim of this study was to compare outcomes for adult LDLT and DDLT via systematic review. A meta-analysis was conducted to examine patient survival and graft survival, MELD, waiting time, technical complications, and postoperative infections. Out of 8600 abstracts, 19 international studies comparing adult LDLT and DDLT published between 1/2005 and 12/2017 were included. U.S. outcomes were analyzed using registry data. Overall, 4571 LDLT and 66,826 DDLT patients were examined. LDLT was associated with lower mortality at 1, 3, and 5 years posttransplant (5-year HR 0.87 [95% CI 0.81-0.93], p < .0001), similar graft survival, lower MELD at transplant (p < .04), shorter waiting time (p < .0001), and lower risk of rejection (p = .02), with a higher risk of biliary complications (OR 2.14, p < .0001). No differences were observed in rates of hepatic artery thrombosis. In meta-regression analysis, MELD difference was significantly associated with posttransplant survival (R

Indexed as

Liver TransplantationAdultGraft SurvivalHumansLiving DonorsRetrospective StudiesTreatment OutcomeWaiting Listsclinical research / practiceliver transplantation / hepatologyliver transplantation: living donormeta-analysis

Identifiers

PMID33300241
PMCPMC9048132
OpenAlexW3111696585

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.